Sam Truex (file photo)
May 10, 2021 11:21 AM EDTUpdated 02:37 PM
People

Af­ter wind­ing down Quench Bio with a bold dose of hon­esty, Sam Truex finds 'per­fect fit' at At­las Ven­ture

Nicole DeFeudis

Editor

When Sam Truex turned out the lights at Quench Bio, she is­sued a heart­felt post out­lin­ing the rea­sons be­hind why the for­mer in­flam­ma­to­ry dis­ease play­er …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

Sanofi, Ope­nAI, For­ma­tion Bio de­but pa­tient re­cruit­ing tool, will use in Phase 3 mul­ti­ple scle­ro­sis stud­ies

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times